1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Align Technology said Executive Vice President and Chief Legal and Regulatory Officer Julie Coletti resigned on July 6, 2026 to join Illumina as its Chief Legal Officer. Her resignation takes effect August 1, 2026. The filing does not name a successor or describe any financial impact.
Julie Coletti resigned July 6, 2026 as EVP, Chief Legal and Regulatory Officer
Resignation is effective August 1, 2026
She is joining Illumina, Inc. as Chief Legal Officer
Copart, Inc. said on July 8, 2026 that Jane Pocock, CEO of its UK operations, will become its new President effective August 1, 2026, filling a previously vacant position. The filing does not disclose financial results or changes to guidance, so the direct financial impact is not stated.
Jane Pocock, 55, joined Copart in January 2019 as Managing Director of Copart UK.
Her appointment as President takes effect August 1, 2026.
Jay Adair is Executive Chairman and incoming Chief Executive Officer, per the press release.
The filing reports no financial results or guidance changes.
Customers Bancorp entered into a Supplemental Executive Retirement Plan for Lyle Cunningham on July 8, 2026, superseding a plan adopted in April 2022. The plan provides lifetime monthly benefits, including a $12,500 monthly payment after normal retirement age, which is a compensation arrangement rather than a change in executive role.
Plan entered July 8, 2026, for executive Lyle Cunningham, replacing his prior plan adopted April 27, 2022
Monthly lifetime benefit of $12,500 payable after separation from service at Normal Retirement Age
Includes early termination and change-in-control benefits, with forfeiture if terminated for Cause
Filed as Exhibit 10.1; the filing does not report any change in officer role
BellRing Brands appointed Michael Axelrod as President and Chief Executive Officer and a board member, effective July 29, 2026. Darcy Davenport will resign from the board, retire as CEO and become an advisor to the company on that date. The filing also sets out Axelrod's pay, equity award, severance and change-in-control terms, which shareholders can review in the company's disclosures.
Annual base salary of $1,000,000, with a target annual bonus of 100% of base salary, paid from 0% to 150% of target
Equity award with a grant date fair value of $4,750,000, 40% in RSUs and 60% in performance-based RSUs
Severance of 2.0 times base salary plus target bonus without a change in control, and 3.0 times if terminated within 6 months before or 24 months after a change in control
Transaction bonus of 100% of annual salary upon a change in control, plus a gross-up agreement covering the Section 4999 excise tax
NAPCO Security Technologies announced that Kevin Buchel, currently President and Chief Operating Officer, will become Chief Executive Officer and President, effective July 8, 2026, while founder Richard Soloway steps down as CEO to become Founder and Executive Chairman. The filing sets out new employment agreements for both executives, including base salaries and severance terms, which matter to shareholders as they define the company's leadership structure and pay commitments.
Kevin Buchel becomes CEO and President; his base salary rises to $900,000 with a target bonus of 50% of base salary
Richard Soloway, who founded NAPCO more than 55 years ago, becomes Founder and Executive Chairman with a base salary of $800,000 and a target bonus of 50% of base salary
Both executives' agreements provide severance equal to two times base salary and target bonus, conditioned on a release of claims
The full employment agreements will be filed as an exhibit to the Form 10-K for the year ended June 30, 2026
Ultra Clean Holdings said Michael Keogh will become its Chief Financial Officer effective August 5, 2026, succeeding Sheri Savage, and will report to CEO James Xiao. The filing sets his annual base salary at $595,000, a target bonus of 85% of salary, and an initial restricted stock unit grant valued at $2,000,000. For shareholders, the change means a new person will lead the company's finance function, and the filing describes his finance background at Ford, Bright Machines, Apple, Stanley Black & Decker and Intel.
Effective date: August 5, 2026; Keogh succeeds Sheri Savage as CFO
Reports to CEO James Xiao
Compensation: $595,000 base salary, 85% target bonus, initial RSU grant valued at $2,000,000
Change-in-control severance agreement: up to 150% of base salary plus annual cash bonus, plus 24 months of COBRA premiums
Alamo Group Inc. said Greg Lucas, formerly CAO and CFO at Thermon Group, accepted a role as Vice President, Corporate Controller and Chief Accounting Officer, and he will become principal accounting officer, replacing Agnes Kamps in that role. Kamps remains Executive Vice President and Chief Financial Officer. The change affects who signs as principal accounting officer, and the filing lists his base salary and incentive terms.
Greg Lucas, 50, is expected to start on or before August 10, 2026, subject to pre-employment screening.
Lucas replaces Agnes Kamps as principal accounting officer; Kamps stays on as EVP and Chief Financial Officer.
Lucas will receive a $335,000 annual base salary, a 40% incentive plan target pro-rated for 2026, and $200,000 in initial restricted stock awards.
The filing says the company is not aware of related party transactions involving Lucas.
Spectral AI appointed Darcy Bajko as Chief Commercial Officer, effective July 31, 2026, to lead commercial functions for the global launch of its FDA-cleared DeepView System for burn indication. The filing sets her base salary at $315,000 and grants options on 150,000 shares, which adds a senior commercial executive and related compensation cost for shareholders.
Darcy Bajko, previously Vice President of Commercialization and Customer Success at MediView XR, starts July 31, 2026.
Base salary of $315,000, with a target bonus of up to 30% of base salary tied to milestones and performance goals.
Stock options for 150,000 common shares under the 2023 Long Term Incentive Plan, vesting annually over three years; options fully vest upon a change of control.
The company's CEO said the first commercial sales of DeepView are targeted by year end 2026.
Power REIT's Board of Trustees appointed Brent Morrison as an independent trustee effective immediately on July 6, 2026. Morrison currently serves as Chairman, CEO and President of Regional Health Properties, Inc., and the Board says his public company experience will provide valuable perspective.
Appointment effective July 6, 2026; Morrison serves until the next annual shareholder meeting or until a successor is elected.
Board determined Morrison meets NYSE American independence requirements.
Morrison will receive the Trust's standard compensation for non-employee trustees.
Filing states no arrangements with other persons for his appointment and no related transactions requiring Item 404(a) disclosure.
Effective July 7, 2026, Hyperion DeFi entered new employment agreements with CEO and Chief Investment Officer Hyunsu Jung, CFO David Knox and General Counsel Robert Rubenstein. The agreements set severance terms, including payments tied to a change in control, and accelerated vesting of equity awards if a change in control occurs while the executive is still employed.
Effective date of the new agreements: July 7, 2026
Knox and Rubenstein may earn cash bonuses of up to 75% and 35% of base salary, respectively, subject to performance goals
Rubenstein's base salary will be $325,000
Severance for Knox and Rubenstein includes 12 months of base salary and up to 12 months of group health benefits; target bonus payable if termination occurs within 12 months after a change in control
Aura Biosciences expanded its board from six to seven directors and appointed Jeremy Bender as an independent Class II director effective July 7, 2026. The filing also discloses an amended director compensation policy, adopted June 11, 2026, that raised the equity awards for new and continuing non-employee directors.
Jeremy Bender, Ph.D., M.B.A., is appointed to fill the newly created seat; his term expires at the 2029 annual meeting of stockholders.
Dr. Bender joins the Compensation Committee and the Nominating and Corporate Governance Committee, effective July 7, 2026.
His initial awards are a stock option for 60,000 shares and an RSU award for 30,000 shares, vesting in equal annual installments over three years.
On June 11, 2026, the annual option award for continuing non-employee directors was raised from 17,000 to 30,000 shares, and the annual RSU award from 13,000 to 15,000 shares.
Moderna's Board appointed Michael McDonnell, former Chief Financial Officer of Biogen Inc., as a director effective July 8, 2026, and placed him on the Audit Committee. The filing describes the appointment as a board change and reports no financial results, guidance, or compensation figures beyond standard non-employee director grants.
Michael McDonnell was appointed to the Board effective July 8, 2026, as a Class II director serving until the 2029 annual meeting.
He served as Chief Financial Officer of Biogen Inc. from August 2020 through February 2025.
He joins the Audit Committee; David Rubenstein left the Audit Committee and joined the Nominating and Corporate Governance Committee.
Ovid Therapeutics said its Chief Business and Financial Officer, Jeffrey Rona, will leave the company effective July 6, 2026, by mutual agreement. The Board appointed Charles Carter, the company's Senior Vice President of Finance and Financial Planning, as Chief Financial Officer, principal financial officer, principal accounting officer and secretary, effective the same day. The company states the departure was not due to any disagreement on accounting, financial statements, internal controls, operations, policies or practices.
Jeffrey Rona's separation date is July 6, 2026; the 8-K says he agreed to leave by mutual agreement, not over any accounting or control disagreement.
Charles Carter, age 59, takes the CFO, principal accounting officer and secretary roles, having served as SVP of Finance and Financial Planning since October 2024.
Carter's pay includes a $460,000 base salary, a target bonus of 35% of base salary, a 50,000-share RSU award vesting in two annual installments from July 6, 2027, and a $75,000 bonus opportunity.
Rona will receive 12 months of base salary, a prorated 2026 bonus and up to 12 months of COBRA benefits, and will provide advisory services through December 31, 2027.
HF Sinclair's board appointed Steven Ledbetter as President and Chief Operating Officer and Valerie Pompa as President, Growth, Technology and Transformation, effective July 6, 2026. Franklin Myers stepped down as President but remains Chief Executive Officer, which the company says is on a temporary basis, so shareholders should watch for a permanent leadership decision.
Steven Ledbetter, 51, was Executive Vice President, Commercial, and his base salary rises from $590,000 to $750,000
Valerie Pompa, 58, was Executive Vice President, Operations, and her base salary rises from $650,000 to $700,000
Franklin Myers ceased to serve as President and continues as Chief Executive Officer on a temporary basis
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.